DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Premier Explosives Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·20 Aug 2026, 5:02 pm

Premier Explosives

Premier Explosives Limited has informed stock exchanges about the transcript from its recent institutional investor meet and conference call. This disclosure is a standard regulatory requirement for listed companies to ensure transparency regarding their interactions with the investment community.

For investors, this update signals that the company is actively engaging with analysts and institutional shareholders. It often precedes the release of detailed financial results or future guidance, providing the market with a clearer picture of the company's strategic direction and operational outlook.

Investors should monitor the transcript for management commentary on order inflows, project execution, and any guidance provided for the upcoming quarters. This information will be crucial for assessing the company's near-term growth prospects and operational health.